4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-25-000153
Chief Medical Officer acquired 44,655 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ho Carole Chief Medical Officer | 2025-08-05 | Option exercise | +44,655 | $0.68 | $30,365 | 220,328 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ho Carole Chief Medical Officer | 2025-08-05 | Option exercise · Stock Option (right to buy) | −44,655 | 62,500 | D: show line 2 in the form |
Loading xslF345X05/wk-form4_1754602468.xml…